Encequidar (mesylate hydrochloride)
Encequidar (HM30181) mesylate hydrochloride is a potent and selective inhibitor of P-glycoprotein (MDR1). Encequidar mesylate hydrochloride improves anti-tumor efficacy of Paclitaxel in mouse tumor models[1][2][3].
Product Specifications
CAS Number
2097125-58-9
Product Name Alternative
HM30181 (mesylate hydrochloride) ; HM30181A (mesylate hydrochloride)
UNSPSC
12352005
Target
P-glycoprotein
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/encequidar-mesylate-hydrochloride.html
Solubility
10 mM in DMSO
Smiles
O=C1C=C(C(NC2=CC(OC)=C(C=C2C3=NN(C4=CC=C(CCN5CC6=CC(OC)=C(C=C6CC5)OC)C=C4)N=N3)OC)=O)OC7=C1C=CC=C7.O=S(O)(C)=O.O
Molecular Formula
C39H42N6O11S
Molecular Weight
802.85
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog